Back to Results
First PageMeta Content
Androgens / Prostate cancer / Androgen deprivation therapy / Testosterone / Prostate / Antiandrogen / Hypogonadism / Cardiovascular disease / Comorbidity / Medicine / Anatomy / Endocrine system


1493 Androgen Deprivation Therapy Increases Cardiovascular Morbidity in Men With Prostate Cancer Christopher S. Saigal, MD, MPH1 John L. Gore, MD1
Add to Reading List

Document Date: 2008-04-18 13:54:32


Open Document

File Size: 145,92 KB

Share Result on Facebook

City

San Francisco / Rotterdam / Geerlings / Detroit / ZIP / Cary / Oakland / San Jose / Monterey / Seattle / Atlanta / Los Angeles / Santa Monica / /

Company

SAS Institute Inc. / Rand Corporation / Veterans Administration Cooperative Urological Research Group / LG / Hak AE / Puget / Wiley InterScience / /

Continent

America / /

Country

Netherlands / United States / /

Currency

USD / ZAR / /

/

Facility

National Institute of Diabetes / Duke University / University of California at Los Angeles / National Cancer Institute / /

/

IndustryTerm

therapy for men with metastatic prostate cancer / carrier/ miles/time/units/service count / treatment for men with localized prostate cancer / health services / treatment for prostate cancer / therapy for advanced prostate cancer / registry site / Hypertension Treatment / therapy for prostate cancer / healthcare / treatment of men with prostate cancer / /

MedicalCondition

Urologic Diseases / metastatic prostate cancer / aortic atherosclerosis / detailed cancer / particularly visceral obesity / Ischemic heart disease / intermediate-risk disease / metastatic disease / severe atherosclerosis / Hypogonadism / angina / coronary heart disease / prostate cancer / leukemia / tumor / Cancer / ST segment depression / elderly male coronary heart disease / chronic stable angina / atherogenesis / Smith MR. Diabetes / SEER national cancer / low-risk disease / localized disease / diabetes / pretreatment cardiac disease / localized prostate cancer / high-risk localized disease / coronary artery disease / higher-risk prostate cancer / hyperinsulinemia / lymphoma / Laakso M. Insulin resistance / Early Prostate Cancer / solid tumors / medically induced hypogonadism / carcinoma / Cardiovascular Morbidity/Saigal et al. obesity / Obesity / bicalutamide Early Prostate Cancer / MS / Prostate Cancer Christopher S. Saigal / congestive heart failure / Results (SEER) Program tumor / advanced prostate cancer / hypertension / disease / atherosclerosis / cardiovascular disease / hyperlipidemia / Pathologic grade unknown Cancer stage Cancer / myocardial infarction / male atherosclerosis / cardiac disease / prostate carcinoma / myocardial ischemia / acutely following myocardial infarction / /

MedicalTreatment

radiotherapy / surgery / prostatectomy / Hormone therapy / Counseling / hormonal therapy / brachytherapy / /

Organization

Kidney Diseases / Medicare / National Institute of Diabetes and Digestive / Division of Urology / US Federal Reserve / American Cancer Society / office of Research / Development / and Information / University of California at Los Angeles / National Cancer Institute / Digestive and Kidney Diseases / Department of Urology / Duke University / Durham / Lauer MS. Association / U.S. Census Bureau / David Geffen School of Medicine / using a linked Medicare / /

Person

Janet Hanley / Matthias Schonlau / Chin Med / Christopher S. Saigal / Mark S. Litwin / Tracey L. Krupski / Chen J. Socioeconomic / /

/

Position

Stern MP / detail physician / general U.S. population / physician / Nilsson PM / comorbidity index using physician / representative / urban and rural regions representative / Diver / Lantz PM / Co- operative / Marshall / /

Product

bicalutamide / diethylstilbestrol / testosterone / /

ProvinceOrState

Hawaii / Connecticut / New Mexico / Utah / California / North Carolina / Iowa / /

RadioStation

Matsumoto AM / /

Technology

coding algorithms / /

URL

www.interscience.wiley.com / /

SocialTag